HTTP/1.1 200 OK
Date: Tue, 22 Oct 2024 03:59:34 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 83601
Connection: keep-alive
Cache-Control: no-cache
Pragma: no-cache
Expires: -1
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Content-Security-Policy: default-src 'self' 'unsafe-eval' 'unsafe-inline' * data:; frame-ancestors 'self'; frame-src 'self' *
SSL Certificate
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
5b:02:b1:48:e6:90:64:46:68:23:93:c0:57:2b:81:7c
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=GB, ST=Greater Manchester, L=Salford, O=Sectigo Limited, CN=Sectigo RSA Organization Validation Secure Server CA
Validity
Not Before: Aug 29 00:00:00 2024 GMT
Not After : Aug 29 23:59:59 2025 GMT
Subject: C=GB, ST=Middlesex, O=GlaxoSmithKline Holdings Ltd, CN=*.gsk-china.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:94:6c:f0:16:7a:df:73:7f:20:38:c0:cc:3e:c6:
31:e8:6a:2f:34:52:87:a2:25:b0:b3:5c:f9:c6:7d:
af:dc:c7:38:cf:3b:29:9c:e5:82:36:f1:16:32:d6:
d7:d6:cc:21:94:d2:75:4f:cf:5a:93:6f:a7:6b:71:
eb:14:b7:87:ec:30:49:50:9f:3c:23:00:80:f8:ec:
03:d6:ce:87:3c:e4:60:2a:27:5b:e0:a2:ff:eb:5c:
af:a8:be:19:b5:68:e9:7c:4b:1b:03:61:79:d5:de:
ad:dd:08:d1:d8:88:17:2b:90:52:69:5e:ad:e1:58:
29:e6:49:ee:98:6c:16:f8:3a:74:a1:20:c0:30:82:
f0:91:1d:ff:16:bb:62:6a:9c:7c:0d:dc:0d:50:a5:
8a:e5:ac:50:3f:ce:c7:d9:e3:f7:22:65:9e:25:07:
ea:85:18:f9:7e:fc:7d:3f:07:85:da:91:0f:88:b2:
e4:5a:a8:21:fe:00:99:68:dc:8c:8d:f9:ca:24:29:
a3:0d:30:02:e1:10:25:d1:30:15:85:3f:33:46:ba:
8c:90:a6:53:7c:6d:d5:06:22:2f:e4:06:f8:26:76:
65:5d:26:37:cf:ea:2b:42:bb:2e:18:2a:2f:5e:b1:
62:f2:60:19:53:61:70:1f:6f:21:c8:99:ba:74:bb:
e5:51
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Authority Key Identifier:
17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB
X509v3 Subject Key Identifier:
50:43:69:6B:9C:34:FF:FD:15:3C:32:E2:38:9F:F9:51:AE:F9:EC:42
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Basic Constraints: critical
CA:FALSE
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Certificate Policies:
Policy: 1.3.6.1.4.1.6449.1.2.1.3.4
CPS: https://sectigo.com/CPS
Policy: 2.23.140.1.2.2
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crl
Authority Information Access:
CA Issuers - URI:http://crt.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crt
OCSP - URI:http://ocsp.sectigo.com
X509v3 Subject Alternative Name:
DNS:*.gsk-china.com, DNS:gsk-china.com
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : DD:DC:CA:34:95:D7:E1:16:05:E7:95:32:FA:C7:9F:F8:
3D:1C:50:DF:DB:00:3A:14:12:76:0A:2C:AC:BB:C8:2A
Timestamp : Aug 29 09:42:19.686 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:7B:9C:6A:89:ED:D3:6A:4E:AB:AF:6C:9F:
6D:59:CC:E6:B8:4B:12:32:FD:A1:3C:B7:72:D5:AB:DE:
75:B3:6A:87:02:21:00:A6:A4:DB:ED:01:81:8D:FA:BB:
7F:A0:A4:7B:5B:8B:3A:8F:1F:21:C3:7D:A8:A7:B4:2C:
A0:EF:B7:DB:9E:44:97
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 0D:E1:F2:30:2B:D3:0D:C1:40:62:12:09:EA:55:2E:FC:
47:74:7C:B1:D7:E9:30:EF:0E:42:1E:B4:7E:4E:AA:34
Timestamp : Aug 29 09:42:19.584 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:46:02:21:00:CC:0A:D4:53:CC:78:AA:A6:FD:FC:FB:
57:F0:BF:D5:77:54:DB:A6:67:E4:EE:E4:5E:1D:E1:28:
E4:55:2F:CB:CB:02:21:00:8E:D3:94:49:D5:C1:78:70:
F6:3B:90:64:C3:1F:0E:0F:4A:E4:ED:5C:CA:E6:71:8E:
75:C8:38:59:A8:B8:FD:7E
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 12:F1:4E:34:BD:53:72:4C:84:06:19:C3:8F:3F:7A:13:
F8:E7:B5:62:87:88:9C:6D:30:05:84:EB:E5:86:26:3A
Timestamp : Aug 29 09:42:19.579 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:6A:FE:2E:C0:71:5C:22:EE:4E:DC:6C:15:
95:B5:25:16:A4:33:62:32:3A:10:CA:59:9E:53:EA:D3:
D3:5B:B2:67:02:21:00:ED:26:47:F4:26:B4:22:65:0C:
99:5B:86:DD:16:76:F0:8D:E1:E7:30:C2:1E:31:26:D4:
7A:58:12:2D:FF:01:32
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
9a:2f:ce:9e:30:03:46:8c:d0:02:61:c5:4a:4c:58:c1:6e:c9:
e8:4f:3a:8c:13:fe:66:4a:9c:ec:af:d7:54:b5:e6:66:24:82:
49:bf:05:fc:d9:5d:20:6a:26:3e:3b:b6:13:ed:31:88:59:31:
f6:0d:d4:89:ab:91:18:a2:87:5d:39:9b:d8:12:21:d4:c8:bf:
9c:79:63:27:e0:b9:bf:d2:58:bb:20:d6:46:96:45:71:80:55:
bb:93:e8:c6:97:69:75:09:67:a2:e9:13:95:fd:91:16:b2:83:
9a:2d:84:72:ea:9d:93:a3:97:c0:01:5f:3b:a9:38:33:84:f7:
00:b9:95:5c:9d:e6:94:81:a4:84:61:cf:c0:a6:ed:b2:30:e3:
9f:5a:f5:8e:d1:fe:1e:f6:b3:7d:d3:f4:bb:4b:c6:61:db:90:
a6:f7:72:b5:7d:7c:fd:cd:4a:10:8c:38:7e:07:5f:bc:63:2a:
fe:80:ec:21:2a:73:cb:9d:79:61:dd:a2:b7:6d:b5:d2:c5:d3:
68:a4:cd:8b:e4:1a:5b:e9:98:64:bb:b9:c1:05:d4:d8:cb:cf:
5f:31:d5:3d:c1:47:61:4e:ac:7f:69:0b:b4:be:2d:d8:79:00:
78:d4:66:94:3d:fa:bc:8a:16:55:c6:0f:1a:0b:e2:d7:f5:46:
39:e2:ac:82
